‌

US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

Patent 12129275 was granted and assigned to SAGE Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

SAGE Therapeutics

0

Current Assignee

SAGE Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ravindra B. Upasani0

Benny C. Askew0

Boyd L. Harrison0

Albert Jean Robichaud0

Jean-Cosme Dodart0

Francesco G. Salituro0

Date of Patent

October 29, 2024

0

Patent Application Number

177073030

Date Filed

March 29, 2022

0

Patent Citations

US Patent 8673843 NMDA receptors modulators and uses thereof

0

US Patent 8829213 Liver X receptor agonists

0

US Patent 10201550 Oxysterols and methods of use thereof

0

US Patent 10227375 Neuroactive steroids and methods of use thereof

0

US Patent 10259840 Oxysterols and methods of use thereof

0

US Patent 10696712 Oxysterols and methods of use thereof

0

US Patent 10723758 Oxysterols and methods of use thereof

0

US Patent 10752653 Oxysterols and methods of use thereof

0

...

Patent Primary Examiner

Barbara P Badio

0

CPC Code

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12129275 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.